Fisons to sell laboratory supplies to Fisher Scientific (US)
This article was originally published in Clinica
Executive Summary
In its third disposal within six months, Fisons (UK) intends to sell most of its laboratory supplies division to Fisher Scientific (US) for $310 million in cash. This sale would pare the UK company down to its $730 million-turnover pharmaceutical business, which is the target of a hostile $2,700 million bid from US-based Rhone-Poulenc Rorer.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.